Frontlight ResearchEarly access
Taking people in United StatesPhase 1
Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis
Key facts
- Who runs it
- VA Office of Research and Development
- Where
- Charleston, United StatesSee the site
- Trial code
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 40 people, planned
- Started
- 1 Jan 2024
- Expected to end
- 31 Dec 2027
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Mesenchymal stem cells
- Placebo
- Record updated
- 7 April 2026
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 23 criteriaShow less
Who can take part
- Age between 18 and 75 years old, male or female
- Definite chronic pancreatitis M-ANNHEIM criteria (Tsimmerman Ia, 2008) One or more of the following are required:
- Pancreatic calcifications
- Moderate or marked ductal lesions
- Marked and persistent exocrine insufficiency defined as pancreatic steatorrhea markedly reduced by enzyme supplementation
- Typical histology of an adequate histological specimen
- Patients who are diagnosed with painful CP for more than 6 months may be constant or may have been waxing and waning/remitting
- Baseline Izbicki pain score > 30 (Dworkin et al., 2005)
- Stable dose of opioids for the past 30 days
Who cannot take part
- Any subject who has had an ongoing alcohol abuse and/or illegal drug dependencies within the past six months
- Any subject who has received an investigational drug or device within 30 days before randomization or who is expected to receive an investigational drug or device during this study
- Patients with planned endoscopic or surgical intervention, surgical resection or needle drainage of pancreatic structures in the next 6 months
- Chronic pain syndromes other than pancreatitis that require daily use of opioids in the past 30 days
- Congestive Heart Failure NYHA class >1
- History of Malignancy except for in situ malignancies that have been surgically treated and basal cell skin cancers
- Evidence of active infection using current antibiotics or with Hepatitis B, C, or HIV
- Known intravenous contrast allergy causing anaphylaxis
- Subjects with infected pancreatic pseudocysts or pancreatic walled-off necrotic areas at the time of consent
- Acute pancreatitis per 2012 revised Atlanta criteria (23) within the last 30 days oThe revised Atlanta classification requires that two or more of the following criteria be met for the diagnosis of acute pancreatitis: (a) abdominal pain suggestive of pancreatitis, (b) serum amylase or lipase level greater than three times the upper normal value, or (c) characteristic imaging findings
- Hemoglobin of <8.0g/dL, EGFR<60 ml/min, AST or ALT >2 times upper limit of normal, Bilirubin > 1.5 mg/dl unless the subject has confirmed Gilbert syndrome., Platelets <100,000/microliter, HbA1c >10%
- Females who are pregnant or women of childbearing potential (WOCBP) and males with female partners of childbearing potential who are not willing to use adequate contraception during the study
- Breastfeeding females
- Subject unwilling to follow the protocol and assessment
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
This trial is currently available in United States.
- Ralph H. Johnson VA Medical Center, Charleston, SCCharleston, United StatesContact: Hongjun N Wang, PhDTaking people
About the trial
What the trial wants to find out
The goal of this clinical trial is to test whether adult stem cells, called mesenchymal stem cells (MSCs) collected from the patient's bone marrow can help reduce pain caused by chronic pancreatitis and improve pancreatic function.
The 2 groups in the trial
- Experimental CohortTreatment being tested
MSC
Treatment: Mesenchymal stem cells
- Validation CohortPlacebo, for comparison
Placebo
Treatment: Placebo
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT05925036, who can take part
- Record updated
- 7 April 2026